Summary.-We have studied the repair of X-ray-induced, potentially lethal damage (PLD) in 9 human tumour lines derived from tumours of varying radiocurability. Cells derived from 3 tumours considered non-radiocurable (1 osteosarcoma, 2 melanoma) repaired significantly more X-ray PLD than cells from 3 tumours considered radiocurable (2 breast, 1 neuroblastoma). The remaining tumour lines were intermediate in their ability for repair, and included cells from another osteosarcoma, a hypernephroma and a glioblastoma. We conclude that the repair of X-ray PLD may be an important cellular determinant of clinical radiocurability.
TUMOUR RADIOCURABILITY (local control) has been thought to depend on variables such as hypoxia, host factors, tumour size and scheduling and delivery of ionizing radiation. These factors have received wide attention in clinical human data analysis and have been extensively studied in animal tumour systems. The cellular and molecular repair processes that may contribute to local control of human neoplasia are less understood. This results both from the ethical problems involved in human experimentation and the relatively slow evolution of in vitro techniques for the study of human tissue.
Plateau-phase cultures have been proposed as useful in vitro models, with certain characteristics of in vivo tumours, particularly as these cultures contain a population of non-cycling cells (Hahn & Little, 1972; Little 1969) . When densityinhibited plateau-phase cultures are treated with X-rays and subculture of the cells at low density is delayed, an enhancement in survival occurs. This phenomenon has been referred to as reflecting the recovery from potentially lethal X-ray damage (PLDR) and is analogous to liquid-holding recovery in bacteria (Hahn & Little, 1972; Little, 1969) . PLDR has been described in animal ascites and solid tumours, as well as established animal tumour lines Shipley et al., 1975) . We have previously examined PLDR in diploid fibroblasts from normal individuals and patients with diseases which demonstrate defects in DNA repair (xeroderma pigmentosum. XP, ataxia telangiectasia, AT) and concluded that PLDR reflected the activity of a molecular repair process . On this basis of the results of another study, we further postulated that the clinical incurability of a human osteosarcoma might be due to efficient PLDR (Weichselbaum et al., 1977b) .
The enhanced survival that occurs when a radiation dose is split with an interval of several hours between fractions has been interpreted as due to the repair of sublethal damage (SLDR) induced by the first dose in cells that survive this dose (Elkind & Sutton, 1959) . The ability of the cells in a tumour to accumulate and repair sublethal damage has been postulated to be a major cellular determinant in radiocurability; the capacity for SLDR has been thought to be reflected by the extrapolation number (n), the back extrapolate of the slope of radiation survival curve for these cells plotted semilogarithmically.
A major factor in the failure of X-rays to sterilize a malignant tumour may be the ability of the cells from that tumour to recover from X-ray damage. We have measured the repair of PLDR and SLDR following X-rays in human tumour lines derived from several types of tumours differing in their clinical radiocurability. We have also continued our systematic investigation of the in vitro radiosensitivity of human tumour cell lines.
MATERIALS AND METHODS
With the exception of melanomias C-32 and C-143, the human tumour lines and methods of establishment and maintenance in culture have been described in previous publications (Weichselbaum et al., 1977a (Weichselbaum et al., , 1980b . In summary, each line was epithelial in morphology, had gone through at least 100 passages in vitro, and continued to proliferate after reaching confluence in a manner not characteristic of normal fibroblasts. Two tumour lines continued to express certain characteristics of the in vivo phenotype (Soule et al., 1973; Weichselbaum et al., 1980b) . MCF-7 (a carcinoma of the breast) had functional steroid receptors, and LAN-1 (a neuroblastoma) typically showed neuronal processes extended from cell bodies. The melanomas C-32 and C-143, which have not been described in our previous publications, have been characterized extensively (Chen & Shaw, 1973; Chen 1978) (Weichselbaum et al., 1977a) Potentially lethal damage recovery (PLDR) is measured in density-inhibited plateauphase cultures exposed to a single dose of X-rays. It is defined as the enhancement in survival when subculture of the cells at low density was delayed for several hours after irradiation. The protocol for the measurement of PLDR is as follows: Cells are plated into 60mm dishes and grown to confluency. Culture medium is renewed for 3 days and the experiment performed on the 4th. Cells are irradiated at room temperature and returned to the incubator. Single plates are removed and cells trypsinized and replated at low density at regular intervals. Medium is changed 5-7 days after irradiation, and 12-18 days later dishes are rinsed, fixed and stained. Only colonies observed under a dissecting microscope to be composed of 50 cells or more are scored as survivors. Results are plotted as recovery ratio vs time of explant; the enhancement of survival after subculture is interpreted as being due to X-ray PLDR. The recovery ratio (R/Ro) is determined by dividing the surviving fraction at each time (R) by the zero-hour survival Ro. R/Ro is used in order to normalize the data from all experiments because of variability in the initial zero-hour survival fraction (S/So). It is the number of colonies counted after irradiation divided by the number of colonies in unirradiated cultures. The doses (5-7 Gy) were designed to yield as nearly as possible the same for the different tumour lines (Table) .
We define sublethal damage repair in exponentially growing cells as the increase in survival when a dose of radiation is split with an interval of several hours between fractions, as compared to the survival when the same total dose is given as a single exposure. The SLDR is predicted by the extrapolation number (n) of the single-dose survival curve. It is measured as follows. Cells are plated and ascertained to be in exponential growth. An X-ray dose (2.5-5 Gy) is selected to obtain a surviving fraction between 0 05 and 0-1. This dose is divided in half and separated by fixed intervals of time from 0 to 10 h and survivors scored as previously described. Results are graphed as recovery ratio vs hours between doses. The enhancement in survival is interpreted as being due to SLDR. R. R. WEICHSELBATJM, A. SCHMIT AND J. B. LITTLE The X-ray survival analysis of the melanoma lines C-32 and C-143 was carried out by the methods previously described (Weichselbaum et at., 1977b (Weichselbaum et at., , 1980a and is as follows. Cells are maintained as stated above. Exponentially growing cultures were treated with 0 25% trypsin in Mg-and Ca-free Earle's balanced salt solution. The dissociated cells were counted in a haemacytometer and plated at low density in 60mm Falcon culture dishes. Cells were irradiated 18 h later: By this time no cell division had yet occurred, and the cells were present singly on the dishes (cell multiplicity= 1). Dishes were returned to the incubator and fixed and stained as above. Each survival curve represents a least-square regression analysis of points from 3 or more experiments. Cloning efficiencies ranged from 4f6 to 6.9%. Cloning efficiency has been shown not to correlate with radiosensitivity (Weichselbaum et al., 1980a, b; Shipley et al., 1975) . The X-ray survival parameters are the Do or radiosensitivity, which is the inverse slope of the straight-line portion of the X-ray survival curve, and the extrapolation number (n), the back extrapolation of the slope to the ordinate.
RESULTS
PLDR was studied by measuring survival as a function of time between Xirradiation of density-inhibited plateauphase cultures and their subculture at low density to measure colony-forming ability. Various parameters for each tumour line, including the 24h recovery ratio, the radiation dose and the zero-time survival, are presented in the Table. The complete, normalized PLDR curves for each tumour line are plotted in the charts.
The results for cell lines C-32 and C-143 (melanomas) and TX-4 (osteosarcoma) irradiated with 7 Gy are shown in Fig. 1 . Recovery ratio is shown on the ordinate, and the interval between irradiation and subculture on the abscissa. The results are pooled from 3 or more separate experiments and normalized to the same initial survival level. The enhancement seen in survival reflects the X-ray PLDR.
The X-ray PLDR with cell lines GBM (glioblastoma), SaOS (osteosarcoma) and PAS (hypernephroma) is shown in Fig. 2 . The recovery ratios for these tumour lines varied from 2-5 to 4-4. PAS shows 4-4-fold recovery at 6 h and 3-fold at 24 h. Each point represents at least 3 experiments. Fig. 3 shows PLDR in tumour lines MCF-7 and MDA (breast cancer) and LAN-1 (neuroblastoma). These types of tumour are generally considered radiocurable. As can be seen in Fig. 3 , PLDR in those lines is less than in the other tumour lines examined. A large standard error was observed at the 8 h PLDR point in LAN-1. Line MDA showed a reproducible decrease in survival at 24 h; 8 and 24 h points are shown in the Table. Again, each point represents at least 3 experiments.
Because PLDR might be related to the proliferative activity which occurs in density-inhibited cultures, and therefore to the fraction of cells in G1, continuouslabelling studies were carried out with the 
DISCUSSION
The curability of malignant tumours may be related both to local control and to the development of metastatic disease. In the tumours described here, we define radiocurability in terms of the ease of local control. On this basis, cells from 3 human tumours considered not clinically radiocurable (2 melanomas and 1 osteosarcoma) demonstrated more PLDR than all the other lines examined in our study (24h recovery ratios ranging from 8 to 20). Three cell lines derived from tumours considered locally radiocurable (2 breast and 1 neuroblastoma) showed least PLDR (24h recovery ratios 1-5-2-0). The other tumour lines, derived from tumours which are also generally considered relatively radioincurable locally, were intermediate in their capacity for X-ray PLDR. Normal diploid fibroblast lines show 3-4-fold PLDR at similar survival levels .
We have demonstrated previously that significant and measurable PLDR takes place in human tumour cells exposed to X-ray doses analogous to the daily doses used in clinical radiotherapy (Weichselbaum et al., 1977b .
Experiments performed to examine sublethal damage repair (SLDR) in exponentially growing cultures of human malignant tumour cells demonstrated no significant differences in their capacity for split-dose recovery, and confirmed that the amount of SLDR may be predicted from the extrapolation number. Although there are no differences between tumours of varying curability in their ability for SLDR, the importance of this phenomenon should not be completely discounted, since all lines examined showed some SLDR, and the ultimate surviving fraction (thus radiocurability) may depend upon combinations of SLDR and PLDR.
We have previously reported that the intrinsic radiosensitivities of a number of human tumour lines, as measured by survival-curve parameters, were very similar (Weichselbaum et al., 1980b) . The human melanoma line C-32, however, is significantly more radioresistant than other tumour lines we have examined. Other investigators have reported some human glioblastoma lines to be radioresistant in vitro, though the frequency of radioresistant cells in vivo is unknown (Gerwick et al., 1977; Nilsson et al., 1980) . Inherent cellular radioresistance may thus, in some cases, be an important factor in clinical radiocurability, though results from several laboratories with a wide variety of human tumour lines have shown few apart from the C-32 melanoma, to be unusually radioresistant in vitro (Smith et al., 1978; Weininger et al., 1978; Wells et al., 1977) .
As has been shown previously (Weichselbaum et al., 1977b; Hahn & Little, 1972) , PLDR generally reflects a change in the slope of the survival curve. For example, osteosarcoma line TX-4 has a Do of 145 in exponential growth, but of 2-01 after 6h repair time (Weichselbaum et al., 1977b) .
Radiocurability is likely to be a highly complex function, and variables other than those discussed here (e.g. hypoxia) will no doubt also be of importance under certain clinical circumstances. We conclude however that the repair of potentially lethal X-ray damage may be a major cellular determinant in human tumour radiocurability.
